We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Visteon
VC
$2.77B
| $127M | 0.16% |
1,152,532
+102,704
| +10% | +$12.8M |
|
152
Ionis Pharmaceuticals
IONS
$9.35B
| $127M | 0.16% |
2,875,025
+185,044
| +7% | +$9.4M |
|
|
SHLX
153
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $126M | 0.16% |
5,965,178
+2,733,613
| +85% | +$72.1M |
|
154
USA Compression Partners
USAC
$3.82B
| $125M | 0.16% |
7,401,395
+871,877
| +13% | +$15.5M |
|
155
Yum China
YUMC
$14.9B
| $124M | 0.16% |
2,997,518
+2,586,604
| +629% | +$111M |
|
156
Coca-Cola
KO
$354B
| $122M | 0.15% |
2,809,381
+1,453,878
| +107% | +$65.3M |
|
|
LOXO
157
DELISTED
Loxo Oncology, Inc
LOXO
| $121M | 0.15% |
1,048,881
-12,230
| -1% | -$1.3M |
|
158
Oneok
OKE
$58.7B
| $121M | 0.15% |
2,123,435
-64,173
| -3% | -$3.68M |
|
|
EEP
159
DELISTED
Enbridge Energy Partners
EEP
| $121M | 0.15% |
12,520,803
-152,150
| -1% | -$2M |
|
160
Vulcan Materials
VMC
$36.3B
| $120M | 0.15% |
1,048,986
+43,541
| +4% | +$5.48M |
|
161
Littelfuse
LFUS
$10.2B
| $118M | 0.15% |
564,531
+212,944
| +61% | +$44.7M |
|
|
SMC
162
Summit Midstream
SMC
$421M
| $117M | 0.15% |
553,420
+11,200
| +2% | +$3.2M |
|
163
Compass Minerals
CMP
$1.24B
| $116M | 0.15% |
1,929,411
+16,748
| +0.9% | +$1.12M |
|
164
Intel
INTC
$466B
| $116M | 0.14% |
2,230,198
+1,211,481
| +119% | +$57.6M |
|
|
AVYA
165
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $113M | 0.14% |
+5,049,928
| New | +$108M |
|
166
Wabtec
WAB
$51.1B
| $112M | 0.14% |
1,374,922
-390,862
| -22% | -$31.5M |
|
167
Antero Midstream
AM
$10.8B
| $112M | 0.14% |
6,999,102
-346,326
| -5% | -$6.7M |
|
168
Alaska Air
ALK
$5.15B
| $112M | 0.14% |
1,801,328
+241,084
| +15% | +$16M |
|
169
DexCom
DXCM
$27.6B
| $111M | 0.14% |
5,978,860
-3,280
| -0.1% | -$48.5K |
|
170
AnaptysBio
ANAB
$1.6B
| $109M | 0.14% |
1,047,114
-12,267
| -1% | -$1.38M |
|
171
Entergy
ETR
$54.1B
| $108M | 0.14% |
2,747,646
+1,193,776
| +77% | +$46.2M |
|
172
LivaNova
LIVN
$4.3B
| $107M | 0.13% |
1,208,021
+1,202,185
| +20,599% | +$102M |
|
173
Wolfspeed
WOLF
$1.2B
| $104M | 0.13% |
2,574,663
+691,708
| +37% | +$26.1M |
|
174
Suburban Propane Partners
SPH
$1.23B
| $103M | 0.13% |
4,680,417
+365,519
| +8% | +$8.92M |
|
175
BioMarin Pharmaceuticals
BMRN
$11.5B
| $102M | 0.13% |
1,261,962
-55,172
| -4% | -$4.73M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.